CLINICAL_TRIALS ClinicalTrials.gov record update

Is Pharmacological Treatment With the Glucagon-like Peptide-1 Receptor Agonist Liraglutide 3mg (Saxenda®) Once-daily a Viable Treatment for Weight Management in Forensic Psychiatry Patients? A Feasibility Study.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04781998
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:38.142048+00:00
Published At: 2023-08-08T00:00:00+00:00
Record Updated At: 2023-08-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Mental Disorder", "Metabolic Disturbance", "Feasibility", "Overweight and Obesity", "Liraglutide"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-08-08"
protocolSection.identificationModule.nctId: "NCT04781998"
protocolSection.identificationModule.officialTitle: "Is Pharmacological Treatment With the Glucagon-like Peptide-1 Receptor Agonist Liraglutide 3mg (Saxenda\u00ae) Once-daily a Viable Treatment for Weight Management in Forensic Psychiatry Patients? A Feasibility Study."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.